Found: 32
Select item for more details and to access through your institution.
Evaluation of Plasma miR-17-5p, miR-24-3p and miRNA-223-3p Profile of Hepatitis C Virus-Infected Patients after Treatment with Direct-Acting Antivirals.
- Published in:
- Journal of Personalized Medicine, 2023, v. 13, n. 8, p. 1188, doi. 10.3390/jpm13081188
- By:
- Publication type:
- Article
Combined Treatment with Antiviral Therapy and Rituximab in Patients with Mixed Cryoglobulinemia: Review of the Literature and Report of a Case Using Direct Antiviral Agents-Based Antihepatitis C Virus Therapy.
- Published in:
- Case Reports in Immunology, 2015, v. 2015, p. 1, doi. 10.1155/2015/816424
- By:
- Publication type:
- Article
Persistence of monoclonal B‐cell expansion and intraclonal diversification despite virus eradication in patients affected by hepatitis C virus‐associated lymphoproliferative disorders.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 2, p. 237, doi. 10.1111/bjh.19002
- By:
- Publication type:
- Article
Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0062965
- By:
- Publication type:
- Article
High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 12, p. 3457, doi. 10.1007/s00277-023-05412-1
- By:
- Publication type:
- Article
Thyroid Autoimmunity and SARS-CoV-2 Infection.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 19, p. 6365, doi. 10.3390/jcm12196365
- By:
- Publication type:
- Article
PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus‐related diseases.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 133, doi. 10.1111/liv.14667
- By:
- Publication type:
- Article
Long‐lasting persistence of large B‐cell clones in hepatitis C virus‐cured patients with complete response of mixed cryoglobulinaemia vasculitis.
- Published in:
- Liver International, 2019, v. 39, n. 4, p. 628, doi. 10.1111/liv.14053
- By:
- Publication type:
- Article
Assessment of free light chains in HCV-positive patients with mixed cryoglobulinaemia vasculitis undergoing rituximab treatment.
- Published in:
- Liver International, 2015, v. 35, n. 9, p. 2100, doi. 10.1111/liv.12829
- By:
- Publication type:
- Article
Rapid improvement of psychiatric stigmata after IFN-free treatment in HCV patients with and without cryoglobulinemic vasculitis.
- Published in:
- Clinical Rheumatology, 2022, v. 41, n. 1, p. 147, doi. 10.1007/s10067-021-05877-3
- By:
- Publication type:
- Article
Dual stimulation by autoantigen and CpG fosters the proliferation of exhausted rheumatoid factor-specific CD21<sup>low</sup> B cells in hepatitis C virus-cured mixed cryoglobulinemia.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2023.1094871
- By:
- Publication type:
- Article
Bone Marrow Immunity and Myelodysplasia.
- Published in:
- Frontiers in Oncology, 2016, p. 1, doi. 10.3389/fonc.2016.00172
- By:
- Publication type:
- Article
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression.
- Published in:
- Rheumatology, 2021, v. 60, n. 9, p. 4418, doi. 10.1093/rheumatology/keab157
- By:
- Publication type:
- Article
Hepatitis B Virus-Related Cryoglobulinemic Vasculitis: Review of the Literature and Long-Term Follow-Up Analysis of 18 Patients Treated with Nucleos(t)ide Analogues from the Italian Study Group of Cryoglobulinemia (GISC).
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 6, p. 1032, doi. 10.3390/v13061032
- By:
- Publication type:
- Article
The Relevance of MicroRNAs in the Pathogenesis and Prognosis of HCV-Disease: The Emergent Role of miR-17-92 in Cryoglobulinemic Vasculitis.
- Published in:
- Viruses (1999-4915), 2020, v. 12, n. 12, p. 1364, doi. 10.3390/v12121364
- By:
- Publication type:
- Article
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity.
- Published in:
- Journal of Clinical Immunology, 2023, v. 43, n. 4, p. 680, doi. 10.1007/s10875-023-01444-4
- By:
- Publication type:
- Article
Assessment of Liver stiffness in patients with HCV and Mixed Cryoglobulinemia undergoing Rituximab treatment.
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 1, doi. 10.1186/1479-5876-12-21
- By:
- Publication type:
- Article
Assessment of liver stiffness in patients with HCV and mixed cryoglobulinemia undergoing rituximab treatment.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact.
- Published in:
- Journal of Translational Medicine, 2012, v. 10, n. 1, p. 158, doi. 10.1186/1479-5876-10-158
- By:
- Publication type:
- Article
B‐cell activating factor (BAFF), BAFF promoter and BAFF receptor allelic variants in hepatitis C virus related Cryoglobulinemic Vasculitis and Non‐Hodgkin's Lymphoma.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 4, p. 658, doi. 10.1002/hon.3008
- By:
- Publication type:
- Article
Opposite Effects of mRNA-Based and Adenovirus-Vectored SARS-CoV-2 Vaccines on Regulatory T Cells: A Pilot Study.
- Published in:
- Biomedicines, 2023, v. 11, n. 2, p. 511, doi. 10.3390/biomedicines11020511
- By:
- Publication type:
- Article
Role of Notch Receptors in Hematologic Malignancies.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 1, p. 16, doi. 10.3390/cells10010016
- By:
- Publication type:
- Article
HCV and Lymphoproliferation.
- Published in:
- Clinical & Developmental Immunology, 2012, p. 1, doi. 10.1155/2012/980942
- By:
- Publication type:
- Article
Impact of direct acting antivirals on hepatitis C virus-related cryoglobulinemic syndrome.
- Published in:
- Minerva Gastroenterology, 2021, v. 67, n. 3, p. 218, doi. 10.23736/S2724-5985.21.02848-8
- By:
- Publication type:
- Article
The metabolic fingerprints of HCV and HBV infections studied by Nuclear Magnetic Resonance Spectroscopy.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-40028-4
- By:
- Publication type:
- Article
Editorial: interferon‐free DAAs are a great boon for patients with hepatitis C and cryoglobulinaemia—Authors’ reply.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 14, p. 11602, doi. 10.3390/ijms241411602
- By:
- Publication type:
- Article
Impact of Immunogenetic IL28B Polymorphism on Natural Outcome of HCV Infection.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Impact of Immunogenetic IL28B Polymorphism on Natural Outcome of HCV Infection.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/710642
- By:
- Publication type:
- Article
Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma.
- Published in:
- Frontiers in Microbiology, 2019, p. N.PAG, doi. 10.3389/fmicb.2019.00475
- By:
- Publication type:
- Article
Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar).
- Published in:
- Internal & Emergency Medicine, 2021, v. 16, n. 1, p. 149, doi. 10.1007/s11739-020-02386-0
- By:
- Publication type:
- Article
The hepatitis C virus infection as a systemic disease.
- Published in:
- Internal & Emergency Medicine, 2012, v. 7, p. 201, doi. 10.1007/s11739-012-0825-6
- By:
- Publication type:
- Article